Proven Scale & Impact

Solution – Your Outsourced International Division

We operate as your dedicated international division—owning the regulatory, commercial, and distributor execution required to scale across global markets. From market prioritization and regulatory pathway design to distributor governance and post-launch performance, we deploy a repeatable operating system that aligns execution, accountability, and investor visibility from day one.

Integrated execution across market access, regulatory pathways, and commercial launch; not siloed workstreams
Single point of accountability for international performance across all regions and partners
Purpose-built operating system for Class II/III devices, diagnostics, and AI/ML-enabled technologies

Savings – Time, Capital, and Execution Risk

Our model eliminates the hidden failure points in global expansion—aligning regulatory, commercial, and distributor execution from day one.

Eliminates mis-sequenced market entry that delays approvals and burns capital
Prevents underperforming distributor partnerships through structured qualification and governance
Aligns regulatory approval, clinical adoption, and commercial launch into a single execution pathway
Reduces rework, relaunches, and lost momentum across international expansion programs

Social Proof – Evidence of Scalable Impact

Our clients range from venture-backed innovators to established manufacturers and healthcare investors building multi-asset portfolios.

Consistent execution across complex, multi-region regulatory and commercial environments
Repeat engagements expanding from initial markets into broader regional portfolios
Proven ability to stabilize underperforming distributor networks and relaunch for growth
Structured, investor-ready reporting that brings clarity to international performance and risk

Get a Quote